Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
4,783,061
-
Share change
-
+2,285,499
-
Total reported value
-
$13,826,384
-
Price per share
-
$2.82
-
Number of holders
-
47
-
Value change
-
+$6,651,253
-
Number of buys
-
33
-
Number of sells
-
14
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q1 2021
As of 31 Mar 2021,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,783,061 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nuveen Asset Management, LLC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, Ensign Peak Advisors, Inc, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, and MARSHALL WACE, LLP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.